dc.contributor.author | Murnane, D. | |
dc.contributor.author | Martin, G.P. | |
dc.contributor.author | Marriott, C. | |
dc.date.accessioned | 2015-03-19T09:18:42Z | |
dc.date.available | 2015-03-19T09:18:42Z | |
dc.date.issued | 2006-09 | |
dc.identifier.citation | Murnane , D , Martin , G P & Marriott , C 2006 , ' Particle aggregation of salmeterol xinafoate (SX) in HFA134a high pressure suspensions ' , Journal of Pharmacy and Pharmacology , vol. 58 , no. Supp 1 , P134 , pp. A49-A50 . https://doi.org/10.1211/002235706778251221 | |
dc.identifier.issn | 0022-3573 | |
dc.identifier.uri | http://hdl.handle.net/2299/15649 | |
dc.description | BPC Science Abstracts | |
dc.format.extent | 2 | |
dc.language.iso | eng | |
dc.relation.ispartof | Journal of Pharmacy and Pharmacology | |
dc.title | Particle aggregation of salmeterol xinafoate (SX) in HFA134a high pressure suspensions | en |
dc.contributor.institution | School of Life and Medical Sciences | |
dc.contributor.institution | Centre for Research into Topical Drug Delivery and Toxicology | |
dc.contributor.institution | Pharmaceutics | |
dc.contributor.institution | Airway Group | |
dc.contributor.institution | Pharmaceutical Analysis and Product Characterisation | |
dc.contributor.institution | Department of Clinical, Pharmaceutical and Biological Science | |
dc.description.status | Peer reviewed | |
rioxxterms.versionofrecord | 10.1211/002235706778251221 | |
rioxxterms.type | Other | |
herts.preservation.rarelyaccessed | true | |